Health overhaul may grow Indiana addiction services
The possibility of thousands of Indiana residents becoming eligible for addiction treatment under the federal health overhaul has state officials and providers preparing for an expansion.
Health Care
Articles
Lilly seeks $30.6M in tax breaks on downtown projects
Indianapolis development officials on Wednesday will weigh the 10-year requests from the pharmaceuticals giant related to a new manufacturing plant and improvements to existing operations downtown.
Analysts: Lilly faces ‘ugly’ period until its pipeline produces
Investor smiles about new experimental cancer drugs and an aggressive play for the animal health market in China turned to frowns after Lilly disclosed deep cuts to its U.S. sales force.
Expected revenue slump spurs Lilly to cut sales force
The Indianapolis pharmaceuticals giant said Thursday that it would lay off hundreds of U.S. sales reps, as it prepares for the loss of patent protection on two of its best-selling drugs.
Employer health coverage on 10-year fall, study says
Indiana, Michigan and South Carolina saw the steepest declines in employer-backed coverage from 2000 to 2011, according to a study released Thursday.
Tyco: No proof Lilly thieves used security report
Lawyers for a security company being sued in the theft of $60 million worth of pharmaceuticals from an Eli Lilly and Co. warehouse in Connecticut say there's no proof the thieves used a report it prepared about security weaknesses in the building.
IU Health to chop $1 billion off costs
Even though Obamacare likely will expand health insurance coverage to an extra 500,000 Hoosiers over the next few years, IU Health expects per-patient reimbursements to fall as the federal government, employers and patients all push back on sky-high health care costs.
Kelley School launching MBA for midcareer physicians
The idea behind the program, which starts in September, is that doctors can no longer leave the business aspect of their jobs to the finance guys while maintaining their integrity as healers.
COLWELL: Indianapolis strategizes for health care reform
The recent flurry of big announcements portends well.
MCDONALD: Groups making headway attacking health problems
The statistics we hear so often are clear. As a community, we are not in an enviable place. We smoke more, exercise less and weigh more than the national average, resulting in more diabetes than average.
Medical finance driving major changes in health care marketplace
Brian and Emily Kahn had virtually identical physical therapy. He paid much more than she did. Why? Because of where the therapy took place.
Lilly warehouse thieves had security report, lawsuit says
A federal lawsuit contends that thieves who broke into an Eli Lilly and Co. warehouse in Connecticut three years ago and stole more than $60 million worth of drugs obtained a copy of a report that revealed weaknesses in the building's security system.
New $100M plan to map human brain could boost Lilly
President Obama on Tuesday announced a campaign designed to develop treatments for some of the least understood brain disorders, an effort that could benefit health care giants Eli Lilly and Co. and others.
Indiana’s health care transparency laws get failing grade
Indiana’s laws requiring hospitals to release price information are woefully inadequate, according to a report by two health insurance reform groups. Indiana was among 29 states to receive an "F" grade.
J&J wins OK for first in new class of diabetes drugs
Johnson & Johnson, the world’s largest seller of health-care products, won approval for the first in a new family of diabetes drugs, giving them the edge against rivals including Eli Lilly and Co. that are developing similar medicines.
Study: Indiana individual health-claim costs to rise
A study by the nation's leading group of financial risk analysts shows the biggest driver of health insurance premiums will rise by more than 67 percent for Indiana residents' individual policies under President Barack Obama's health care overhaul.
Lilly, Boehringer submit diabetes drug to FDA
Eli Lilly and Co. said Monday that it has submitted a new type 2 diabetes treatment it is developing with German drugmaker Boehringer Ingelheim to the Food and Drug Administration.
Indiana lawmakers advance tighter cold meds limits
Consumers would face tighter limits on the quantities they could buy of cold and allergy pills often used to make methamphetamine under a proposal approved by Indiana lawmakers.
HealthLease to snare $141.7M in senior properties
A central Indiana REIT that went public in 2012 has agreed to buy 13 senior housing and care facilities in three states, growing its asset value by 50 percent.
Court may decide if drugmakers can pay to delay generics
Federal regulators are pressing the Supreme Court to stop big pharmaceutical corporations from paying generic drug competitors to delay releasing their cheaper versions of brand-name drugs. They argue these deals deny American consumers, usually for years, steep price declines.